COGT - Financial Reports List - Cogent Biosciences, Inc. - IntrinsicAlpha

Cogent Biosciences, Inc. COGT

Healthcare - Biotechnology - NASDAQ - US

$ 4.355

-1.6 %

$ 496 M

Market Cap

-2.22

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	0.00%	-24.95%	-26.63%
Annual Report	FY	10-K	2024-12-31	0.00%	-32.98%	-32.58%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-27.54%	-26.58%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-33.75%	-36.75%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-71.93%	-44.33%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	-53.18%	-33.11%
Annual Report	FY	10-K	2023-12-31	0.00%	-45.06%	-40.78%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-66.30%	-61.81%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-26.19%	-31.32%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	-13.69%	-37.62%

1